TOPICS: Reye syndrome, fulminant liver failure, encephalopathy, aspirin, mitochondrial damage, microvesicular steatosis, hyperammonemia, cerebral edema, hypoglycemia, elevated liver enzymes, hepatomegaly, nausea, coma, viral hepatitis, hepatitis A, fecal oral, hepatitis B, chronic disease, hepatitis C, parenteral, hepatocellular carcinoma, hepatitis D, HBV co-infection, superinfection, hepatitis E, pregnant women, alcohol related liver disease, acetaldehyde, hepatocyte swelling, Mallory bodies, cytokeratin filaments, fat deposition, painful hepatomegaly, cirrhosis, non-alcoholic fatty liver disease, obesity, fatty deposition, hemochromatosis, excess iron, hemosiderosis, free radical, primary hemochromatosis, HFE gene, C282Y, DMT-1, hepcidin, ferroportin, secondary hemochromatosis, iron transfusions, cirrhosis, type 2 diabetes, bronze skin, dilated cardiomyopathy, cardiac arrhythmia, gonadal dysfunction, TIBC, % saturation, Prussian blue stain, hepatocellular carcinoma, phlebotomy, wilson disease, excess copper, autosomal recessive, ATP7B gene, ceruloplasmin, hydroxyl free radicals, behavioral changes, dementia, chorea, Parkinson symptoms, Kayser Fleischer rings, D-penicillamine, chelating agent
